TrialTranslational psychiatry2026

Discovery of a potential novel pharmacogenomic biomarker on ANK3 gene for liafensine, a triple reuptake inhibitor for treatment-resistant depression.

Wen Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.